HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Chromium Picolinate Proposed UK Advisory “Completely Unjustified” – CRN

This article was originally published in The Tan Sheet

Executive Summary

The UK Food Standards Agency consumer advisory asking citizens to avoid using chromium picolinate dietary supplements due to the ingredient's possible association with cancer is flawed, the Council for Responsible Nutrition asserts May 13

You may also be interested in...



Chromium Picolinate Again Deemed Safe By UK Agency

The UK Food Standards Agency has lifted precautions on consumption of chromium picolinate by reversing a previous advisory warning the public to avoid the ingredient

Melatonin, Chromium Monograph Human Safety Data Should Be Used – CRN

Animal and in vitro studies are not useful in crafting safety monographs for melatonin and chromium picolinate because there is adequate human data available, according to Council for Responsible Nutrition VP-Nutritional & Regulatory Science John Hathcock, PhD

Vitamin/Mineral Raw Material Suppliers EC Dossier Submissions Urged

Raw material suppliers of vitamins or minerals not included on the European Commission's positive list of food supplements should submit dossiers for the ingredients' addition to the list as soon as possible, supplement industry reps advise

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS128871

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel